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Patellar Tendinopathy: “Jumper’s 
Knee”
Mayur Nayak and Rahul Yadav
Abstract
“Patellar tendinopathy” is also known as “Jumper’s knee” and is a common cause 
of impaired function in athletes who participate in sports that require jumping 
and running activities. The exact etiology of disease is still unknown and several 
theories have been postulated for its pathogenesis. It usually presents as anterior 
knee pain that is related to the sports activity and might lead to decreased sports 
participation. USG and MRI are the main modality of investigation that aids in 
the diagnosis. Non-operative therapy forms the main stay of treatment in form of 
rest, brace, physical therapy and anti-inflammatory medications. Other adjuncts 
such as cryotherapy, corticosteroids injection, platelet -rich plasma injections and 
electrical therapy like TENS or ESWT have been used with some success. Operative 
intervention in form of open or arthroscopic procedures are reserved for chronic 
and refractory cases.
Keywords: patellar tendinopathy, degenerative, tendinitis, jumper’s knee, enthesis, 
eccentric, cryotherapy
1. Introduction
Tendinopathy is a broad term encompassing painful condition in and around 
tendon due to overuse. It commonly affects the Extensor mechanism (patellar 
tendon) around the knee and is termed as “jumper’s knee” [1, 2]. It is characterized 
by an initial reactive or inflammatory response followed by stage of degeneration. 
The prevalence of patellar tendinosis is seen greatest in young adults who are engaged 
in high demand sports that involves running, jumping and cutting movements. It 
has been estimated to range from 40%-50% in elite volleyball players and 35%-40% 
in high level basketball players [3]. It can also affect sedentary individuals and an 
estimated prevalence of 14.2% is seen in general population [4].
The disease pass through two stages, acute and chronic and presentation vary 
according to the stage of disease. It usually present as anterior knee pain, swelling 
and impaired function in acute stage, while in chronic stage it may presents as long 
standing anterior knee pain with profound muscle wasting without the sign of 
inflammation or impaired function. The tendo-osseous junction on the inferior pole 
of patella is the usual affected site. The exact etiology of disease is still unknown. 
However, various risk factor have been identified which may contribute in develop-
ment of patellar tendinopathy such as impaired quadriceps flexibility and strength, 
high body mass index (BMI), leg length discrepancy, impaired hamstring flexibility 
and vertical jump performance, as all these factors increases the strain over the 
patellar tendon [5]. Several theories have been postulated on pathogenesis of patellar 
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tendinopathy including vascular [6], mechanical [7], nervous [8] and impingement 
related. However the chronic repetitive tendon overload theory is the most accepted 
theory for patellar tendinosis.
The term “patellar tendinitis” which is often used for patellar tendon pain 
appears to be misnomer for patellar tendinopathy. Multiple histo-pathological 
studies have reported that the primary pathology in most of painful tendon is 
degenerative rather than inflammatory [9–11]. However Fredberg et al. [12] chal-
lenged the concept of patellar tendon pain due to degenerative cause and stated that 
it is rather the presence of inflammatory process that is responsible for pain. While 
some histopathological studies [13, 14] have shown that pro-inflammatory chemical 
agent such as cyclooxygenase, growth factors, and prostaglandins are present in 
acute stages and macrophage and lymphocyte in chronic tendinopathy, we still need 
further research and more evidences to prove the theory.
The management of patellar tendinopathy has always been challenge to the 
healthcare professionals. It usually requires a multimodal approach and based upon 
the current literature and clinical practice an effective conservative intervention in 
the form of rest, NSAIDS and physiotherapy is indicated in acute phase and surgical 
procedure are reserved for chronic and long standing cases.
2. Anatomy
Patellar tendon is the continuation of the common tendon of insertion of quadri-
ceps, extending from the inferior pole of patella to the tibial tuberosity. In adult, the 
patellar tendon is around 25–40 mm wide in the coronal plane and 4–5 mm deep in 
the sagittal plane and 4–6 cm long. Macroscopically it appears white, glistening and 
stringy with collagen fiber in tendon are arranged in parallel fashion.
The blood supply of the tendon is through the anastomotic vascular ring lying 
in the thin layers of loose connective tissue that covers the fibrous expansion of the 
rectus femoris. The formation of the ring is through the anterior tibial recurrent 
artery and genicular arteries mainly the lateral superior, lateral inferior and medial 
inferior artery [15, 16].
The patellar tendon attachment to bone (patella or tibia) has fibrocartilaginous 
enthesis with four distinct tissue zones–dense fibrous connective tissue, uncalci-
fied fibrocartilage, calcified cartilage and bone [17]. The patellar tendon lack of 
well-developed proper paratenon, while the posterior surface of tendon which is 
in direct contact of fat pad, which is highly vascular and innervated. According to 
Duri et al. [18] the intensity of pain in some patient with patellar tendinopathy is 
due to involvement of fat pad. Patellar tendon pathology usually involve the enthesis 
site, it most commonly involve the inferior pole of patella but can also involve tibial 
tubercle or proximal aspect of patella in quadriceps tendon. Macroscopically the 
diseased portion of tendon become disorganized and appears yellow-brown in color.
3. Epidemiology
Jumper’s knee is commonly seen in people involved in contact sports such as 
basketball, volleyball, high jump, long jump, tennis and running [1]. The factor con-
tributing factor in development of patellar tendinopathy can be classified as extrinsic 
factor or intrinsic factor [19]. The intrinsic factor can be sex, race, bone structure, 
bone density, muscle length, muscle strength, joint range of motion. While extrinsic 
factors are training volume (duration, frequency and intensity), specific sports 
activity, specific movements like quick acceleration, deceleration, cutting action and 
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training surfaces. Ferreti [20] observed direct relation between the patellar tendi-
nopathy with number of weekly training session and training over the hard surface.
The condition is more commonly seen in males than females [21]. This condition 
is not a self-limiting one and symptoms may prevail after treatment.
4. Pathogenesis
Tendons display a classical stress-strain curve, during the increased flexion the 
maximum load is located in deep posterior portion of patella, close to center of rota-
tion knee and inferior pole of patella. The crimp pattern of the tendon disappears 
when the length of the tendon is stretched greater than 2%. With further stretch 
greater than 5%, the tendon fibers become more parallel and the tendon follows a 
linear response to stress [22, 23]. Beyond this, tendon failure starts to begin with 
disruption of collagen cross links.
The force experienced by patellar tendon on a level ground while walking is 0.5 
kN, which increases to 8 kN during landing from a jump, 9 kN during fast running 
and further to 14.5 kN during competitive weight lifting. A basketball player, on 
an average, jumps 70 times per game where the vertical component of the ground 
reaction force reaches to about six to eight times the body weight. Thus, sport activi-
ties can impose high levels of stress on the tendon, enough to cause its failure. This 
increased strain result in alteration of cellular activity level by affecting the tenocytes 
and altering the protein and enzyme production with deforming of nucleus [7, 24]. 
The tendon fibroblast are loaded with increased prostaglandins E2, leukotrienes 
B4, VEGF and matrix metalloproteinase which contribute to tendinopathy. This 
increased strain result in alteration of cellular activity level by affecting the tenocytes 
and altering the protein and enzyme production with deforming of nucleus [7, 24]. 
The tendon fibroblast are loaded with increased prostaglandins E2, leukotrienes B4, 
VEGF and matrix metalloproteinase which contribute to tendinopathy.
In chronic patellar tendinopathy, there will be absent or minimal inflammation 
[10, 13, 21]. The diseased tendon shows hypercellularity with atypical fibroblast and 
endothelial cell proliferation with neovascularization [13, 21, 25, 26]. There will be loss 
of longitudinal collagen fibers and demarcation between collagen bundles with relative 
expansion of tendon. There will be abundant number of cell undergoing apoptosis 
with abundance of pre-apoptotic proteins and gene [27, 28]. Macroscopically tendi-
nopathy will have disorganized appearance described as mucoid degeneration [20, 29].
5. History and physical examination
The clinical diagnosis of jumper’s knee is based on the subjective sensation of the 
pain and restriction of activities. The symptoms are insidious in onset but usually 
relates to an increase in frequency or intensity of activity involving rapid repetitive 
ballistic movements of the knee joint. It starts with a dull aching pain in the anterior 
aspect of the knee after a strenuous activity and further progresses to a state where 
it interferes with the performance of the individual. Patients also complain of pain 
while ascending or descending stairs.
The key physical finding of the patellar tendinopathy is tenderness at the inferior 
pole of patella when the knee is at full extension with gradual decrease in the pain 
when the knee is flexed gradually. It is generally accompanied by few signs of soft 
tissue inflammation [1]. The condition often associated with abnormalities of 
patellar tracking, chondromalacia patellae, Osgood-schlatter disease or mechanical 
malalignment of the leg.
Tendons
4
6. Imaging
6.1 Roentgenogram
Anteroposterior, lateral and tangential views of patella may show radiolucency 
over involved pole in early stage, while in prolonged stage, the involved pole may 
appear elongated. In chronic cases tendon calcification and periosteal reaction over 
anterior aspect of patella (“tooth sign”) may be evident. While in long standing 
cases the stress fracture or disruption of extensor mechanism may occur.
6.2 Ultrasonography
Ultrasound and MRI is the main modality of investigation for jumper’s knee. 
Although CT scan can image patellar tendon, it does not offer any significant advan-
tage over the above mentioned investigations. However studies have shown CT scan 
to be of some prognostic value [30, 31].
Role of ultrasound:
1. Detect preclinical lesion in athletes
2. Detect patellar tendon pathology and assess its severity
Ultrasonographic appearance:
Patellar tendons in patients suffering from jumper’s knee have decreased echo-
genicity, containing either a sonolucent region or diffuse hypoechogenicity [31–33]. 
The tendon envelope is irregular, and there may be erosion of patellar tip and 
intratendinous calcification may be present.
6.3 Role of MRI
1. Identification of exact location and the extension of the tendon involvement
2. Exclusion of other condition such as bursitis, chondromalacia
3. Quantification of the size of patellar tendon to be excised during surgery
Appearance in MRI:
The abnormal patellar tendon contains an oval to round area of high signal 
intensity in T1- and T2-sequence at the tendon attachment site or focal zones of 
high signal intensity in the deeper zones of the tendon [34, 35]. The T2-weighted 
sequences (particularly the T2*-weighted GRE sequences) have greater sensitivity 
than the T1-weighted protocols. However, the T1-weighted signal can image most 
cases of patellar tendinopathy.
Ferrati et al. [36] classified jumper’s knee into six stages according to symptoms:
Stage Symptoms
0 No pain
1 Pain only after intense sports activity, no undue functional impairment
2 Pain at the beginning and after sports activity, still able to perform at a satisfactory level
3 Pain during sports activity, increasing difficulty in performing at a satisfactory level
4 Pain during sports activity, unable to participate in sports at as satisfactory level
5 Pain during daily activity, unable to participate in sport at any level
5Patellar Tendinopathy: “Jumper’s Knee”
DOI: http://dx.doi.org/10.5772/intechopen.84642
7. Management
Unfortunately the management used for chronic tendon disorders has a very 
little scientific backdrop and varies considerably among the surgeons and across 
countries. Thus the treatments listed below are at best empirical.
7.1 Rest
This modality is useful in athletes presenting for the first time with patellar pain 
but becomes a concern in individuals involved in competitive sports.
7.2 Straps, braces and exercises
One approach to help in healing of the tendon tissues is unloading. This can be 
achieved either by the modification of the activities for e.g. decreasing the number 
of jumps or landing on the ground with proper orientation of the foot, or use of 
knee braces and straps such as chopart straps that share and alter the load on the 
tendon. Chopart strap [10] is a tape attached just proximal to tibial tendon. The 
most popular non-operative treatment involves eccentric exercise.
7.3 Cryotherapy and physical modalities
Cryotherapy helps in controlling initial tissue response to the injury. It is thought 
to act by decreasing the blood flow and metabolic rate, thereby decreasing the rate 
of inflammation. Electrical modalities that have been used in patellar tendinopathy 
include ESWT, ultrasound, heat, interferential therapy, magnetic fields, pulsed 
magnetic and electromagnetic fields, transcutaneous electrical nerve stimulation 
(TENS), and laser [10, 37, 38]. The true effects of the above mentioned modalities 
still remain unknown and further studies are required to support their use.
7.4 Remedial massage
It tends to treat the tendon tissue by having an effect on the muscle stretch and 
direct effect on the tendon cells. Muscle belly massage is thought to increase the 
compliance of the muscle and decrease the load on the muscle. Deep friction mas-
sage is thought to activate the mesenchymal cells to stimulate the healing response. 
“Fibrolysis”, a form of deep frictional massage originally developed in Finland, 
has been successful in Achilles tendinopathy. However a controlled study failed to 
provide any evidence of healing in patellar tendinopathy and further evidence is 
required to warrant its use [39].
7.5 Rehabilitation
The key treatment nowadays to chronic tendinopathy is the stretching and 
strengthening programme of the whole muscle tendon unit. A staged program for 
tendinopathy corresponding to the stages of worsening severity of the condition [1] 
was outlined by Stanish et al. [40] outlined in Table 1.
Drop squat forms one of the key exercise for this condition in which patients 
are asked to sit to about 100–120° of knee flexion from a standing position and are 
advised to perform three sets consisting of 10 repetitions per session. It was observed 
that this regimen brought about complete relief in 30% of patients with reduction in 
the symptoms in further 64% of the patients [41]. Worsening symptoms were seen 
in the remaining 6% of patients. Cannell [42] observed that eccentric squats were 
better as compared to leg curl/extension exercises in treatment of the condition.
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7.6 NSAIDS
Although the benefits of NSAIDs are dubious, they are the most common 
drug used for symptomatic relief [43]. Although the use of “anti-inflammatory” 
medication seems paradoxical for a condition that is essentially degenerative, it 
is believed NSAIDs might act via mechanisms different from their conventional 
anti-inflammatory actions [44]. In vitro studies in human cartilage have revealed a 
variable interaction of NSAIDs with glycosaminoglycans (GAGs) where some have 
been shown to stimulate and some to inhibit, its synthesis [45]. This mechanism 
also sheds light on its effect on the synthesis of extra-cellular matrix. In a double 
blinded placebo controlled study, the use of NSAIDs in tendinopathy, piroxicam did 
not benefit patients with Achilles tendinopathy however topical ketoprofen reached 
the target tissue in patients with patellar tendinopathy, but the clinical efficacy was 
not assessed [46].
7.7 Corticosteroids
Corticosteroids are known for reducing the symptoms arising from the inflamed 
synovial structures. However the role of corticosteroids remains controversial in 
management of tendinopathy. According to Jozsa and Kannus [47] steroids are 
contraindicated in acute phase of tendinopathy and in the late chronic phase of 
tendinopathy when the tendon degeneration is advanced which may lead to tendon 
rupture. However it has proved beneficial when diluted with anesthetic for diag-
nostic reasons and to minimize adverse effects and in conditions where 1–6 week 
rest period combined with a programme of gradual strengthening is required before 
returning to activity.
7.8 Other medical treatments
Aprotinin, an 85 amino acid 65 kDa basic polypeptide extracted from bovine 
lungs has shown to offer better pain relief than steroids at least in short term. 
However aprotinin which is a strong inhibitor MMP (matrix metalloproteinase) is 
less effective in insertional tendinopathy as compared to main body [48]. Another 
non-surgical treatment option includes use of sclerosing agent with chemical 
irritant (e.g. polidocanol) [8, 49, 50]. These targets the neovascularization and 
accompanying nerves. The use of platelet-rich plasma injection has been tried in 
tendinopathy and favorable outcome have been found [51–53]. However still there is 
no level 1 or level II studies about role of PRP in patellar tendinopathy. The glyceryl 
trinitrate (GTN) patch [54, 55], which delivers nitric oxide (NO) to pathological 
tendon which play role in tendon healing. But we still need level1or level II evidence 
to support it.
Stage Program
Stage 1 Adequate warm up
Ice after activity
Local anti-inflammatory treatments, including non-steroidal anti-inflammatory drugs (NSAIDs)
Physiotherapy(isometric quadriceps exercises and an elastic knee support)
Stage 2 Addition of period of rest and heat before activity
Stage 3 Addition of prolonged period of rest
Table 1. 
Program for patellar tendinopathy.
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7.9 Surgical treatment
Patellar tendon surgery is indicated in patients who have failed conservative 
management more than 6 weeks [56–58]. A variety of surgical procedures have 
been described such as resection of the tibial attachment of the patellar tendon 
with realignment, drilling of the inferior pole of the patella, macroscopic necrotic 
area excision [59], repair of macroscopic defects, longitudinal tenoplasty/tenotomy 
of the tendon [60] percutaneous longitudinal tenotomy, percutaneous needling 
[61] and arthroscopic assisted decompression [62, 63] of the tendon, possibly with 
excision of the inferior pole of the patella however the effectiveness of any single 
procedure has not been elucidated.
8. Conclusions
Patellar tendinopathy is essentially a degenerative condition and the 
management should be based on the clinical assessment. Imaging appear-
ances, although aids in the diagnosis but should not determine the treatment. 
Conservative treatment forms the mainstay of management, while surgery is 
indicated only after a dedicated period of appropriate conservative measures 
have been instituted, usually around 6–9 months. These include physical 
modalities such as local application of ice and graduated strengthening phys-
iotherapy protocol such as functional exercises and eccentric strengthening; 
the latter are done only after the patient is pain free. Although there is a lack 
of level I evidence, eccentric training appears to be the most promising modal-
ity. Peritendinous corticosteroid or aprotinin infiltration may also be useful as 
an adjunct for the treatment of this condition. Although scientific consensus 
is lacking percutaneous needling appears to be the least invasive procedure, 
followed by percutaneous longitudinal tenotomy. Arthroscopic debridement has 
been proposed, but, although early results are encouraging, its efficacy is still 
under scrutiny.
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BMI body mass index
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VEGF vascular endothelial growth factor
MRI magnetic resonance imaging
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GRE gradient echo sequence
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TENS transcutaneous electrical nerve stimulation
MMP matrix metalloproteinase
PRP platelet rich plasma
GTN glyceryl tri-nitrate
NO nitric oxide
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